Go With Us
"Go With Us!" to Conferences. This is a one-of-a-kind experience for people affected by AiArthritis diseases to learn more about research (pharmacologic and non-pharmacologic) and get insights from fellow patients how to use the information discussed to improve your healthcare journey. These posts highlight the information we have learned at these conferences.
Find What You Are looking For
Discover the latest research about Sjögren's Disease presented at ACR24.
The progress seen at ACR 2024 is a testament to the power of research and collaboration. Discover more inside.
Cell therapy involves using a patient’s own cells or donor cells to reset the immune system.
Fatigue, brain fog , sleep and mental health are some of the most common and debilitating symptoms of rheumatic diseases, but often misunderstood or dismissed during medical consultations.
The discovery of new biomarkers in rheumatoid arthritis (RA) is opening doors to more personalized and effective treatments.
The recent developments in biosimilars are creating waves in the world of rheumatology and beyond, offering promising solutions to improve patient care. However, understanding the complexities of these treatments and their integration into healthcare systems is crucial for ensuring their benefits are fully realized.
Breakthroughs in Sjogren’s disease and psoriatic arthritis treatments revealed at ACR Convergence 2024 promise improved care and quality of life for patients. The future of rheumatology is here!
Precision Medicine, Ageism, Fatigue, and More - Public Debrief #EULAR2022
EULAR 2024: Leila's Updates on Exercise and Fatigue
Key Insights Becky emphasizes during 2024 EULAR detailed examination of opioid utilization, pain management, and fatigue in rheumatology.
